Adverse analytical finding
An adverse analytical finding (AAF), also known as a testing positive, occurs when a laboratory accredited by the World Anti-Doping Agency (WADA) "identifies the presence of a prohibited substance and/or its metabolites or markers in a…
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
An adverse analytical finding (AAF), also known as a testing positive, occurs when a laboratory accredited by the World Anti-Doping Agency (WADA) "identifies the presence of a prohibited substance and/or its metabolites or markers in a sample". A related concept is the atypical finding (ATF) when the result is inconclusive, a category introduced in 2008.
Not all AAFs result in anti-doping sanctions; the rate varies by sport. In athletics, the rate of AAFs does not vary significantly by event and averages 0.95 percent of samples analyzed. However, sprinters were more likely to test positive for anabolic steroids while middle- and long-distance runners were more likely to test positive for peptides and growth factors.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1371048105 under CC BY-SA 4.0; modifications have been made.